Rachel Kelly1,2, Monique Albert1, Manon de Ladurantaye3, Melissa Moore4, Olusola Dokun5, John M S Bartlett1,2. 1. 1Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Canada. 2. 2Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Canada. 3. 3Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Canada. 4. 4Ontario Health Study, Ontario Institute for Cancer Research, Toronto, Canada. 5. 5Health Services Research, Ontario Institute for Cancer Research, Toronto, Canada.
Abstract
Background: It is widely assumed that the integrity of tissue specimens remains stable indefinitely if preserved at cryogenic temperatures. With biobanking reaching a level of maturity where samples are increasingly stored for 10 years and beyond, this assumption of prolonged stability should be tested. Data from such an assessment are critical to verify if samples stored for extended durations remain "fit for purpose" or if there is need to reconsider the utility of samples stored beyond a certain timeframe. The Ontario Tumour Bank has been collecting samples since 2004, and assesses a random selection of frozen samples each year for RNA and DNA integrity as a part of ongoing quality control (QC) practices. This historical quality assessment data provide a unique opportunity to assess the impact of extended storage on nucleic acid integrity using replicate samples that remain in the bank in the present day as comparators. Methods: To examine the stability of fresh-frozen tumor tissue stored at cryogenic temperatures, RNA was extracted and analyzed from 87 cases over 14 disease sites stored long term in vapor-phase liquid nitrogen (LN2) (approximately -180°C). Historical QC data were compared against new data after re-extraction of replicate samples to determine the effect of extended storage on RNA quality. In addition, DNA was extracted from a subselection of samples (n = 20) to determine the effect of prolonged storage on DNA integrity. Results: No time-dependent decrease in tissue RNA or DNA quality, as measured by RNA integrity number (RIN) and DNA integrity number, was observed over an 11-year period. As a secondary observation, RNA integrity was not predictive of DNA integrity: DNA quality may still be very good, and as such RIN scores should not be used as a substitute indicator for evaluating DNA. Conclusions: Extended cryogenic storage beyond 2-11 years remains a viable option for maintaining the high quality of specimens in biobanks.
Background: It is widely assumed that the integrity of tissue specimens remains stable indefinitely if preserved at cryogenic temperatures. With biobanking reaching a level of maturity where samples are increasingly stored for 10 years and beyond, this assumption of prolonged stability should be tested. Data from such an assessment are critical to verify if samples stored for extended durations remain "fit for purpose" or if there is need to reconsider the utility of samples stored beyond a certain timeframe. The Ontario Tumour Bank has been collecting samples since 2004, and assesses a random selection of frozen samples each year for RNA and DNA integrity as a part of ongoing quality control (QC) practices. This historical quality assessment data provide a unique opportunity to assess the impact of extended storage on nucleic acid integrity using replicate samples that remain in the bank in the present day as comparators. Methods: To examine the stability of fresh-frozen tumor tissue stored at cryogenic temperatures, RNA was extracted and analyzed from 87 cases over 14 disease sites stored long term in vapor-phase liquid nitrogen (LN2) (approximately -180°C). Historical QC data were compared against new data after re-extraction of replicate samples to determine the effect of extended storage on RNA quality. In addition, DNA was extracted from a subselection of samples (n = 20) to determine the effect of prolonged storage on DNA integrity. Results: No time-dependent decrease in tissue RNA or DNA quality, as measured by RNA integrity number (RIN) and DNA integrity number, was observed over an 11-year period. As a secondary observation, RNA integrity was not predictive of DNA integrity: DNA quality may still be very good, and as such RIN scores should not be used as a substitute indicator for evaluating DNA. Conclusions: Extended cryogenic storage beyond 2-11 years remains a viable option for maintaining the high quality of specimens in biobanks.
Entities:
Keywords:
DNA integrity; RNA integrity; frozen biospecimens; quality assurance; quality control
Authors: Ligia Craciun; Selim Alex Spinette; Marc Rassy; Roberto Salgado; Alexandre de Wind; Pieter Demetter; Laurine Verset; Maria Gomez-Galdon; Marie Chintinne; Nicolas Sirtaine; Nicolas de St Aubain; Ioanna Laios; Francoise Roy; Denis Larsimont Journal: Front Med (Lausanne) Date: 2019-10-17
Authors: Lucas Caldi Gomes; Ana Galhoz; Gaurav Jain; Anna-Elisa Roser; Fabian Maass; Eleonora Carboni; Elisabeth Barski; Christof Lenz; Katja Lohmann; Christine Klein; Mathias Bähr; André Fischer; Michael P Menden; Paul Lingor Journal: Clin Transl Med Date: 2022-01
Authors: Maximilian Babel; Andreas Mamilos; Stephan Seitz; Tanja Niedermair; Florian Weber; Tobias Anzeneder; Olaf Ortmann; Wolfgang Dietmaier; Christoph Brochhausen Journal: Sci Rep Date: 2020-09-01 Impact factor: 4.379